首页> 外文OA文献 >Determination of moxifloxacin in dried blood spots using LC-MS/MS and the impact of the hematocrit and blood volume
【2h】

Determination of moxifloxacin in dried blood spots using LC-MS/MS and the impact of the hematocrit and blood volume

机译:使用LC-MS / MS测定干血斑中的莫西沙星以及血细胞比容和血容量的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Moxifloxacin (MFX) is a potential oral agent use in the treatment of multidrug-resistance tuberculosis (MDR-TB). Due to variability in pharmacokinetics and in vitro susceptibility of causative bacteria, therapeutic drug monitoring (TDM) of MFX is recommended. Conventional plasma sampling for TDM is facing logistical challenges, especially in limited resource areas, and dried blood spots (DBS) sampling may offer a chance to overcome this problem. The objective of this study was to develop a LC-MS/MS method for determination of MFX in dried blood spots (DBS) that is applicable for TDM. The influence of paper type, the hematocrit (Hct) and the blood volume per spot (V(b)) on the estimated blood volume in a disc (V(est)) was investigated. The extracts of 8mm diameter discs punched out from DBS were analyzed using liquid chromatography tandem mass spectrometry (LC-MS/MS) with cyanoimipramin as internal standard. The method was validated with respect to selectivity, linearity, accuracy, precision, sensitivity, recovery and stability. The effect of Hct and V(b) on LC-MS/MS analytical result was also investigated. The relationship between MFX concentrations in venous and finger prick DBS and those in plasma was clinically explored. V(est) was highly influenced by Hct while the effect of V(b) appeared to be different among paper types. Calibration curves were linear in the range of 0.05-6.00 mg/L with inter-day and intra-day precisions and biases of less than 11.1%. The recovery was 84.5, 85.1 and 92.6% in response to blood concentration of 0.15, 2.50 and 5.00 mg/L, respectively. A matrix effect of less than 11.9% was observed. MFX in DBS was stable for at least 4 weeks at room condition (temperature of 25°C and humidity of 50%). A large range of Hct value produced a significant analytical bias and it can be corrected with resulting DBS size. A good correlation between DBS and plasma concentrations was observed and comparable results between venous DBS and finger prick DBS was attained. This fully validated method is suitable for determination of MFX in dried blood spot and applicable for TDM.
机译:莫西沙星(MFX)是潜在的口服药物,可用于治疗耐多药结核病(MDR-TB)。由于药代动力学的变化和致病菌的体外敏感性,建议使用MFX进行治疗药物监测(TDM)。传统的TDM血浆采样面临着物流方面的挑战,尤其是在资源有限的地区,干血斑(DBS)采样可能为克服这一问题提供了机会。这项研究的目的是开发一种适用于TDM的LC-MS / MS方法来测定干血斑(DBS)中的MFX。研究了纸张类型,血细胞比容(Hct)和每点血量(V(b))对椎间盘估计血量(V(est))的影响。使用氰基亚胺精作为内标,使用液相色谱串联质谱(LC-MS / MS)分析从DBS冲出的8mm直径圆盘的提取物。该方法在选择性,线性,准确性,精密度,灵敏度,回收率和稳定性方面得到了验证。还研究了Hct和V(b)对LC-MS / MS分析结果的影响。临床上探讨了静脉和手指刺DBS中MFX浓度与血浆中MFX浓度之间的关系。 V(est)受Hct的影响很大,而V(b)的影响在纸张类型之间似乎有所不同。校准曲线在0.05-6.00 mg / L范围内是线性的,日间和日间精度以及偏差小于11.1%。血液浓度分别为0.15、2.50和5.00 mg / L时,回收率分别为84.5、85.1和92.6%。观察到基质效应小于11.9%。 DBS中的MFX在室温(温度为25°C,湿度为50%)下稳定至少4周。 Hct值的较大范围会产生明显的分析偏差,并且可以使用生成的DBS大小进行校正。观察到DBS与血浆浓度之间具有良好的相关性,并且在静脉DBS和手指刺DBS之间获得了可比的结果。这种经过充分验证的方法适用于测定干血斑中的MFX,适用于TDM。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号